slide1 n.
Download
Skip this Video
Loading SlideShow in 5 Seconds..
ICHV Division of Pharmacy Division of Oncology PowerPoint Presentation
Download Presentation
ICHV Division of Pharmacy Division of Oncology

Loading in 2 Seconds...

play fullscreen
1 / 1

ICHV Division of Pharmacy Division of Oncology - PowerPoint PPT Presentation


  • 113 Views
  • Uploaded on

Work with cytotoxic drugs : overview of different hospitals’ wards in Valais, Switzerland. Buchmann S 1 , Obrist R 2 , Marty S 1 Institut Central des Hôpitaux Valaisans, SION, Switzerland 1 Division of Pharmacy 2 Division of Oncology sophie.buchmann@ichv.ch.

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about 'ICHV Division of Pharmacy Division of Oncology' - mae


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
slide1

Work with cytotoxic drugs : overview of different hospitals’ wards in Valais, Switzerland

Buchmann S 1, Obrist R 2, Marty S 1

Institut Central des Hôpitaux Valaisans,

SION, Switzerland

1Division of Pharmacy

2Division of Oncology

sophie.buchmann@ichv.ch

32nd European Symposium on Clinical Pharmacy VALENCIA 29.10 – 1.11.2003

ICHV

Division of Pharmacy

Division of Oncology

Background and objective

Evaluation of the work with cytotoxic drugs in different hospitals’ wards in Valais, Switzerland. Because of the geographic dissemination of those hospitals (fig.1), all depending on the Central Pharmacy, which is halfway located, there is no centralised cytotoxics’ preparation existing yet. The aim of this study is to identify sources of errors (fig.2) and try to reduce potential for chemotherapy-related mistakes.

Design

Initially literature's review and guidelines on the subject and visits in two Universitary Hospitals working with a centralised cytotoxics’ preparation at the Pharmacy. Then, local evaluation with a check-list (fig.3) concerning prescription, drugs’ order at the Central Pharmacy, preparation and finally treatment’s administration.

Setting

10 wards working with cytotoxic drugs in different hospitals in Valais, Switzerland.

Main outcome measures

Comparison of the different wards’ results with the literature's recommendations, guidelines and with the way of work in the two visited Universitary Hospitals. (fig.4)

50 km

Fig. 1 : Location of the six regional hospitals in Valais

Fig. 2 : Example of dangerous drugs’ order

received at the Central Pharmacy

Fig. 3 : Check-list’s first page

Results

Most of the divergences from the literature's recommendations have been found at the stages of prescription and preparation of cytotoxic drugs. The prescriptions are not necessarily given in a procedure form and are not always clear enough for the nursing staff. Safety precautions during the preparation of cytotoxic drugs are not always applied in optimal way. Contamination’s risks for both the nursing staff and the prepared drugs exist. Medicines’ orders at the Pharmacy and treatment’s administration are the stages with a lower risk of problems.

Fig. 4 : Example of results’ analysis table

Conclusions

The study shows problems within the process which could generate serious complications for patients and for the nursing staff. The improvements that a Central Pharmacy can propose, in order to decrease the risk of mistakes are : standardization of procedures for chemotherapy for all the prescribers, including all informations that the nursing staff needs, plus local support for the preparation of cytotoxic drugs. Eventually centralisation of cytotoxic drugs’ preparation at the Central Pharmacy, considering difficulties ensuing geographical distribution of hospitals. The implication of the clinical pharmacist in such a process may be essential to reduce risks with the cytotoxic drugs.